Scilex Holding Co

Scilex Holding Company, filing under ticker VCKA, is a post-merger specialty pharmaceutical company focused on non-opioid pain management therapies. The company resulted from the business combination between Scilex and Vickers Vantage Corp. I, a healthcare-focused blank-check company that completed its IPO in 2021 and was sponsored by Vickers Venture Fund. Operating within the specialty pharma segment of the broader healthcare sector, Scilex develops and commercializes products targeting acute and chronic pain conditions. The December 2025 8-K filing reflects the company's continued activity as a public reporting entity following the completed de-SPAC transaction. Sign up for full data on SpacDesk to access complete filing histories, timeline analytics, and deal intelligence on this and thousands of other SPAC transactions.